Search Within

Jedd D Wolchok

  1. "Adult Leukemia"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (4)
  3. Book Section (1)
Groups
  1. Adult Leukemia (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. GSK Faculty (17)
  5. Hematologic Malignancies, Division of (17)
  6. Melanoma and Immunotherapeutics Service (17)

More Groups

People
  1. Paul Chapman (6)
  2. Taha Merghoub (6)
  3. Omar Abdel-Wahab (5)
  4. Raajit Rampal (5)
  5. Virginia Klimek (5)
  6. Arnab Ghosh (4)

More People

Years
  1. 2022 (1)
  2. 2021 (3)
  3. 2020 (2)
  4. 2016 (2)
  5. 2014 (1)
  6. 2012 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (2)
  2. Blood (1)
  3. Cancer Immunology Research (1)
  4. Cancer Immunology, Immunotherapy (1)
  5. Clinical Cancer Research (1)
  6. Clinics in Plastic Surgery (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Biomed Central Ltd (2)
  3. Nature Publishing Group (2)
  4. American Association for the Advancement of Science (1)
  5. American Society of Hematology (1)
  6. Elsevier Inc. (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
    Journal Article

    Gigoux, M.; HolmstroĢˆm, M. O.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; George, M.; Venkatesh, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • CD8(+) T cells contribute to survival in patients with COVID-19 and hematologic cancer
    Journal Article

    Bange, E. M.; Han, N. A.; Wileyto, P.; Kim, J. Y.; Gouma, S.; Robinson, J.; Greenplate, A. R.; Hwee, M. A.; Porterfield, F.; Owoyemi, O.; more...
    Nature Medicine (2021)

    Fulltext@MSK | Save
  • Checkpoint blockade in melanoma patients with underlying chronic lymphocytic leukemia
    Journal Article

    Smithy, J. W.; Pianko, M. J.; Maher, C.; Postow, M. A.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Wolchok, J. D.; Park, J. H.; Callahan, M. K.
    Journal of Immunotherapy (2021)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Heteroclitic peptide cancer vaccine counters MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J. J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L. M. B.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal of Immunology (2020)

    Fulltext@MSK | Save
  • Kinase regulation of human MHC class i molecule expression on cancer cells
    Journal Article

    Brea, E. J.; Oh, C. Y.; Manchado, E.; Budhu, S.; Gejman, R. S.; Mo, G.; Mondello, P.; Han, J. E.; Jarvis, C. A.; Ulmert, D.; more...
    Cancer Immunology Research (2016)

    Fulltext@MSK | Save
  • The future of cancer treatment: Immunomodulation, CARs and combination immunotherapy
    Journal Article

    Khalil, D. N.; Smith, E. L.; Brentjens, R. J.; Wolchok, J. D.
    Nature Reviews Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Appendices
    Book Section

    Olson, A. L.; Glass, J. L.; Wolchok, J. D.; Meisel, J. L.; Stabler, S. M.; Chung, S. S.; Lunning, M. A.; Michael, A. G.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save